Adequacy of 6-month follow-up in chemotherapy trials.
Marais
B J
BJ
van Helden
P D
PD
Donald
P R
PR
D000995:Antitubercular Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D017720:Molecular Epidemiology; D012008:Recurrence; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*
D000995:Antitubercular Agents